Encountering Pharmacogenetic Test Results in the Psychiatric Clinic.
作者信息
Bousman Chad A, Mukerjee Gouri, Men Xiaoyu, Dorfman Ruslan, Müller Daniel J, Thomas Roger E
机构信息
Departments of Medical Genetics, Psychiatry, Physiology & Pharmacology, and Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.
Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
出版信息
Can J Psychiatry. 2022 Feb;67(2):95-100. doi: 10.1177/07067437211058847. Epub 2021 Nov 16.
Abstract
摘要
相似文献
1
Encountering Pharmacogenetic Test Results in the Psychiatric Clinic.
Can J Psychiatry. 2022 Feb;67(2):95-100. doi: 10.1177/07067437211058847. Epub 2021 Nov 16.
2
Facilitators and Barriers to the Adoption of Pharmacogenetic Testing in an Inner-City Population.
Pharmacotherapy. 2018 Feb;38(2):205-216. doi: 10.1002/phar.2077. Epub 2018 Jan 21.
3
An Expiration Date for Pharmacogenetic Test Results and Prescribing Guidance?
J Appl Lab Med. 2023 Jul 5;8(4):826-830. doi: 10.1093/jalm/jfad016.
4
Individualizing pharmacogenomic test results in the context of the microbiome.
Per Med. 2020 Nov;17(6):459-468. doi: 10.2217/pme-2020-0077. Epub 2020 Oct 7.
5
Preemptive Panel-Based Pharmacogenetic Testing: The Time is Now.
Pharm Res. 2017 Aug;34(8):1551-1555. doi: 10.1007/s11095-017-2163-x. Epub 2017 May 2.
6
Is Pharmacogenetic Testing a Vital Tool for Enhancing Therapeutic Management of Patients Worldwide?
Clin Pharmacol Ther. 2024 Oct;116(4):885-889. doi: 10.1002/cpt.3404.
7
Clinical pharmacogenetics: how do we ensure a favorable future for patients?
Pharmacogenomics. 2018 Apr;19(6):553-562. doi: 10.2217/pgs-2017-0192. Epub 2018 Apr 5.
8
Pharmacotherapies and personalized medicine for alcohol use disorder: a review.
Pharmacogenomics. 2020 Oct;21(15):1117-1138. doi: 10.2217/pgs-2020-0079. Epub 2020 Aug 18.
9
Pharmacogenetics: The perspective of a routine use of pharmacogenetic testing in psychiatric clinical practice.
Psychiatry Res. 2021 Nov;305:114236. doi: 10.1016/j.psychres.2021.114236. Epub 2021 Oct 12.
10
The Routine Clinical use of Pharmacogenetic Tests: What it Will Require?
Pharm Res. 2017 Aug;34(8):1544-1550. doi: 10.1007/s11095-017-2128-0. Epub 2017 Feb 24.
引用本文的文献
1
Hypertension precision medicine: the promise and pitfalls of pharmacogenomics.
Pharmacogenomics. 2025 Apr-Apr;26(5-6):183-206. doi: 10.1080/14622416.2025.2504865. Epub 2025 May 27.
2
Approaches and hurdles of implementing pharmacogenetic testing in the psychiatric clinic.
PCN Rep. 2022 Jun 22;1(2):e26. doi: 10.1002/pcn5.26. eCollection 2022 Jun.
3
The emergence, implementation, and future growth of pharmacogenomics in psychiatry: a narrative review.
Psychol Med. 2023 Dec;53(16):7983-7993. doi: 10.1017/S0033291723002817. Epub 2023 Sep 29.
4
Genetics.
J Can Acad Child Adolesc Psychiatry. 2022 May;31(2):100-102. Epub 2022 May 1.
本文引用的文献
1
An Evidence-Based Framework for Evaluating Pharmacogenomics Knowledge for Personalized Medicine.
Clin Pharmacol Ther. 2021 Sep;110(3):563-572. doi: 10.1002/cpt.2350. Epub 2021 Jul 22.
2
Chronic Inflammatory Status Observed in Patients with Type 2 Diabetes Induces Modulation of Cytochrome P450 Expression and Activity.
Int J Mol Sci. 2021 May 7;22(9):4967. doi: 10.3390/ijms22094967.
3
Sequence2Script: A Web-Based Tool for Translation of Pharmacogenetic Data Into Evidence-Based Prescribing Recommendations.
Front Pharmacol. 2021 Mar 18;12:636650. doi: 10.3389/fphar.2021.636650. eCollection 2021.
4
Characterization of Pharmacogenetic Information in Food and Drug Administration Drug Labeling and the Table of Pharmacogenetic Associations.
Ann Pharmacother. 2021 Oct;55(10):1185-1194. doi: 10.1177/1060028020983049. Epub 2020 Dec 31.
5
Review and Consensus on Pharmacogenomic Testing in Psychiatry.
Pharmacopsychiatry. 2021 Jan;54(1):5-17. doi: 10.1055/a-1288-1061. Epub 2020 Nov 4.
6
Phenoconversion of Cytochrome P450 Metabolism: A Systematic Review.
J Clin Med. 2020 Sep 7;9(9):2890. doi: 10.3390/jcm9092890.
7
Effect of High-Dose Esomeprazole on CYP1A2, CYP2C19, and CYP3A4 Activities in Humans: Evidence for Substantial and Long-lasting Inhibition of CYP2C19.
Clin Pharmacol Ther. 2020 Dec;108(6):1254-1264. doi: 10.1002/cpt.1949. Epub 2020 Aug 2.
8
Pharmacogenetic Testing Options Relevant to Psychiatry in Canada: Options de tests pharmacogénétiques pertinents en psychiatrie au Canada.
Can J Psychiatry. 2020 Aug;65(8):521-530. doi: 10.1177/0706743720904820. Epub 2020 Feb 17.
9
"Black box" pharmacogenetic decision-support tools in psychiatry.
Braz J Psychiatry. 2020 Apr;42(2):113-115. doi: 10.1590/1516-4446-2019-0724. Epub 2020 Jan 24.
10
Recommendations for Clinical CYP2C9 Genotyping Allele Selection: A Joint Recommendation of the Association for Molecular Pathology and College of American Pathologists.
J Mol Diagn. 2019 Sep;21(5):746-755. doi: 10.1016/j.jmoldx.2019.04.003. Epub 2019 May 8.
Zotero 插件